These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F. Nefrologia; 2008 Apr; 28 Suppl 3():39-48. PubMed ID: 19018737 [Abstract] [Full Text] [Related]
13. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators. Circulation; 2009 Apr 14; 119(14):1883-91. PubMed ID: 19332468 [Abstract] [Full Text] [Related]
14. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study]. Krupicka J, Ceypová K, Kristenová P, Hauser T. Vnitr Lek; 2008 Nov 14; 54(11):1031-8. PubMed ID: 19069675 [Abstract] [Full Text] [Related]
18. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, Borgioni C, Gentile G, Reboldi G. J Hypertens; 2009 Aug 14; 27(8):1697-704. PubMed ID: 19424088 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS. Clin Ther; 2009 May 14; 31(5):988-98. PubMed ID: 19539099 [Abstract] [Full Text] [Related]